Ernexa Therapeutics Inc. (ERNA) SEC filings
ERNA SEC filings moved a median of -0.72% by the close. ERNA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ERNA overview →
81 measured ERNA SEC filing events.
Where these ERNA SEC filings landedvs 81 measured ERNA SEC filing reactions
| Middle 50% of ERNA SEC filing reactions | -6.93% to +2.06% |
|---|---|
| Median reaction (to close) | -0.72% |
| Measured reactions | 81 |
Point-in-time · zero look-ahead
Half of the 81 ERNA SEC filing events with a measured close landed between -6.93% and +2.06%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Ernexa Therapeutics Inc. For: Oct 15 | SEC filing · Form 8-K | — | -4.57% | |
| Form 8-K Ernexa Therapeutics Inc. For: Sep 14 | SEC filing · Form 8-K | +0.99% | -6.93% | |
| Form 8-K Ernexa Therapeutics Inc. For: Sep 16 | SEC filing · Form 8-K | +0.99% | -6.93% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -3.88% | |
| Form 8-K Ernexa Therapeutics Inc. For: Jul 01 | SEC filing · Form 8-K | +0.00% | +2.06% | |
| Form 8-K Ernexa Therapeutics Inc. For: Jul 02 | SEC filing · Form 8-K | +0.00% | +2.06% | |
| Form 8-K Ernexa Therapeutics Inc. For: Jun 22 | SEC filing · Form 8-K | — | +1.74% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.54% | +60.99% | |
| Form ARS Ernexa Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | -1.54% | +60.99% | |
| Form DEF 14A Ernexa Therapeutics Inc. For: May 11 | SEC filing · Form DEF | -1.54% | +60.99% | |
| Form DEFA14A Ernexa Therapeutics Inc. | SEC filing · Form DEFA14A | -1.54% | +60.99% | |
| Form 8-K Ernexa Therapeutics Inc. For: May 01 | SEC filing · Form 8-K | -1.52% | +1.27% | |
| Form DEF 14C Ernexa Therapeutics Inc. For: Apr 13 | SEC filing · Form DEF | -5.62% | -3.00% | |
| Form PRE 14C Ernexa Therapeutics Inc. For: Apr 01 | SEC filing · Form PRE | +2.48% | -0.74% | |
| Form EFFECT Ernexa Therapeutics Inc. | SEC filing · Form EFFECT | -2.44% | +2.31% | |
| Form S-3/A Ernexa Therapeutics Inc. | SEC filing · Form S-3 | -3.12% | -0.57% | |
| Form 8-K Ernexa Therapeutics Inc. For: Mar 18 | SEC filing · Form 8-K | -1.84% | -7.84% | |
| Form S-3 Ernexa Therapeutics Inc. | SEC filing · Form S-3 | +0.00% | +0.67% | |
| Form 10-K Ernexa Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.67% | |
| Form 8-K Ernexa Therapeutics Inc. For: Feb 26 | SEC filing · Form 8-K | +2.21% | -1.69% | |
| Form 8-K Ernexa Therapeutics Inc. For: Feb 06 | SEC filing · Form 8-K | -2.44% | +18.34% | |
| Form EFFECT Ernexa Therapeutics Inc. | SEC filing · Form EFFECT | -4.45% | -5.92% | |
| Form 8-A12B Ernexa Therapeutics Inc. | SEC filing · Form 8-A12B | +2.33% | -7.14% | |
| Form CERT Ernexa Therapeutics Inc. | SEC filing · Form CERT | -0.13% | -0.19% | |
| Form S-1/A Ernexa Therapeutics Inc. | SEC filing · Form S-1 | — | -13.94% | |
| Form S-1/A Ernexa Therapeutics Inc. | SEC filing · Form S-1 | -7.95% | -7.88% | |
| Form S-1 Ernexa Therapeutics Inc. | SEC filing · Form S-1 | +0.00% | -21.36% | |
| Form 8-K Ernexa Therapeutics Inc. For: Dec 11 | SEC filing · Form 8-K | +0.78% | +18.40% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.25% | +0.00% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | — | +1.25% | |
| Form 8-K Ernexa Therapeutics Inc. For: Jun 30 | SEC filing · Form 8-K | — | +5.50% | |
| Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development | Press release | -2.88% | -5.05% | |
| Form EFFECT Ernexa Therapeutics Inc. | SEC filing · Form EFFECT | -3.60% | -7.20% | |
| Form 8-K Ernexa Therapeutics Inc. For: Jun 12 | SEC filing · Form 8-K | -2.43% | +1.33% | |
| Form S-3 Ernexa Therapeutics Inc. | SEC filing · Form S-3 | -6.54% | -8.85% | |
| Form S-8 Ernexa Therapeutics Inc. | SEC filing · Form S-8 | -6.54% | -8.85% | |
| Form 8-K Ernexa Therapeutics Inc. For: Jun 09 | SEC filing · Form 8-K | -16.67% | -13.89% | |
| Form 8-K Ernexa Therapeutics Inc. For: Jun 02 | SEC filing · Form 8-K | -3.04% | -20.79% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | -8.05% | -10.32% | |
| Form EFFECT Ernexa Therapeutics Inc. | SEC filing · Form EFFECT | -1.25% | -4.43% | |
| Form S-3 Ernexa Therapeutics Inc. | SEC filing · Form S-3 | +0.00% | +3.12% | |
| Form ARS Ernexa Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +0.05% | -0.35% | |
| Form DEF 14A Ernexa Therapeutics Inc. For: Dec 31 | SEC filing · Form DEF | +0.05% | -0.35% | |
| Form D Ernexa Therapeutics Inc. | SEC filing · Form D | +0.00% | +4.30% | |
| Form 8-K Eterna Therapeutics Inc. For: Mar 31 | SEC filing · Form 8-K | +2.73% | +2.84% | |
| Form PRE 14A Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form PRE | +2.39% | +7.69% | |
| Form 8-K Eterna Therapeutics Inc. For: Mar 26 | SEC filing · Form 8-K | +0.84% | -3.49% | |
| Form 8-K Eterna Therapeutics Inc. For: Mar 20 | SEC filing · Form 8-K | -5.62% | -7.55% | |
| Form 10-K Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.76% | +1.80% | |
| Form 8-K Eterna Therapeutics Inc. For: Mar 11 | SEC filing · Form 8-K | +0.76% | +1.80% | |
| Form 8-K Eterna Therapeutics Inc. For: Feb 07 | SEC filing · Form 8-K | -0.29% | -1.19% | |
| Form 8-K Eterna Therapeutics Inc. For: Jan 03 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Eterna Therapeutics Inc. For: Dec 30 | SEC filing · Form 8-K | +12.97% | +9.93% | |
| Form EFFECT Eterna Therapeutics Inc. | SEC filing · Form EFFECT | -2.13% | -6.03% | |
| Form D Eterna Therapeutics Inc. | SEC filing · Form D | +1.00% | -4.11% | |
| Form 10-Q Eterna Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -20.34% | |
| Form S-1 Eterna Therapeutics Inc. | SEC filing · Form S-1 | -4.27% | -4.27% | |
| Form 8-K Eterna Therapeutics Inc. For: Oct 29 | SEC filing · Form 8-K | -0.91% | +0.00% | |
| Form ARS Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +1.96% | -6.96% | |
| Form DEF 14A Eterna Therapeutics Inc. For: Oct 07 | SEC filing · Form DEF | — | -1.94% | |
| Form 8-K Eterna Therapeutics Inc. For: Sep 24 | SEC filing · Form 8-K | -3.22% | -11.02% | |
| Form PRE 14A Eterna Therapeutics Inc. For: Sep 27 | SEC filing · Form PRE | -3.22% | -11.02% | |
| Form 8-K Eterna Therapeutics Inc. For: Sep 24 | SEC filing · Form 8-K | +14.17% | +5.83% | |
| Form 8-K Eterna Therapeutics Inc. For: Sep 17 | SEC filing · Form 8-K | -11.90% | -10.32% | |
| Form 8-K Eterna Therapeutics Inc. For: Aug 16 | SEC filing · Form 8-K | +6.46% | -0.72% | |
| Form 10-Q Eterna Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -3.06% | |
| Form 10-Q Eterna Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -9.79% | |
| Form 8-K Eterna Therapeutics Inc. For: Mar 19 | SEC filing · Form 8-K | -1.01% | -2.11% | |
| Form 10-K/A Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -4.00% | +4.44% | |
| Form 10-K Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +6.86% | |
| Form 8-K Eterna Therapeutics Inc. For: Feb 12 | SEC filing · Form 8-K | — | +7.74% | |
| Form EFFECT Eterna Therapeutics Inc. | SEC filing · Form EFFECT | — | +18.49% | |
| Form 8-K Eterna Therapeutics Inc. For: Jan 17 | SEC filing · Form 8-K | +5.15% | +5.15% | |
| Form S-8 Eterna Therapeutics Inc. | SEC filing · Form S-8 | — | -1.32% | |
| Form S-3 Eterna Therapeutics Inc. | SEC filing · Form S-3 | +0.00% | -1.27% | |
| Form 8-K Eterna Therapeutics Inc. For: Dec 14 | SEC filing · Form 8-K | +0.00% | +4.27% | |
| Form D Eterna Therapeutics Inc. | SEC filing · Form D | — | -0.59% | |
| Form 8-K Eterna Therapeutics Inc. For: Dec 08 | SEC filing · Form 8-K | +2.75% | -17.03% | |
| Form 8-K Eterna Therapeutics Inc. For: Nov 14 | SEC filing · Form 8-K | +4.42% | +0.00% | |
| Form 10-Q Eterna Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.77% | |
| Form 8-K Eterna Therapeutics Inc. For: Oct 30 | SEC filing · Form 8-K | +0.00% | -5.38% |
Keep exploring
More ERNA: earnings → · analyst actions → · ERNA overview →